---
trial_id: 261
discovery_date: 2022-03-29 21:28:28.014457
date: 2022-03-29 21:28:28.014457
title: "A SINGLE ARM, OPEN LABEL MULTICENTRE EXTENSION STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB IN
PATIENTS WITH MULTIPLE SCLEROSIS PREVIOUSLY ENROLLED IN A F. HOFFMANN-LA ROCHE SPONSO..."
summary: |
  <p>EudraCT Number: 2017-004886-29<br />Sponsor Protocol Number: MN39158<br />Sponsor Name: Roche Farma SA (Soc unipersonal) que realiza el ensayo en España y que actúa como representante F.Hoffmann-La Roche Ltd<br />Start Date: 2018-05-22<br />Medical condition: Multiple sclerosis (MS)<br />Disease: <br />Version: 20.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br />Version: 20.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10048393<br />Term: Multiple sclerosis relapse<br />Level: PT<br />Version: 20.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br />Version: 20.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10039720<br />Term: Sclerosis multiple<br />Level: LLT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/ES">ES</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/EE">EE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/IE">IE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/CZ">CZ</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/FR">FR</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/DK">DK</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/SE">SE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/FI">FI</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/NL">NL</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/GB">GB</a> (GB - no longer in EU/EEA), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/BE">BE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/SI">SI</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/PL">PL</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/PT">PT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/SK">SK</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/BG">BG</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/HU">HU</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/IT">IT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/HR">HR</a> (Ongoing)</p>
link: 'https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-004886-29'
published_date: NaT
trial_source: Clinical Trials Register Europe
relevant: 
options:
  unlisted: false
---
<p>EudraCT Number: 2017-004886-29<br />Sponsor Protocol Number: MN39158<br />Sponsor Name: Roche Farma SA (Soc unipersonal) que realiza el ensayo en España y que actúa como representante F.Hoffmann-La Roche Ltd<br />Start Date: 2018-05-22<br />Medical condition: Multiple sclerosis (MS)<br />Disease: <br />Version: 20.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10028245<br />Term: Multiple sclerosis<br />Level: PT<br />Version: 20.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10048393<br />Term: Multiple sclerosis relapse<br />Level: PT<br />Version: 20.0<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10063399<br />Term: Relapsing-remitting multiple sclerosis<br />Level: PT<br />Version: 20.1<br />SOC Term: 10029205 - Nervous system disorders<br />Classification Code: 10039720<br />Term: Sclerosis multiple<br />Level: LLT<br /><br />Population Age: Adults<br />Gender: Male, Female<br />Trial Protocol: <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/ES">ES</a> (Prematurely Ended), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/EE">EE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/IE">IE</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/CZ">CZ</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/FR">FR</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/DK">DK</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/SE">SE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/FI">FI</a> (Completed), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/NL">NL</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/GB">GB</a> (GB - no longer in EU/EEA), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/BE">BE</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/SI">SI</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/PL">PL</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/PT">PT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/SK">SK</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/BG">BG</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/HU">HU</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/IT">IT</a> (Ongoing), <a href="https://www.clinicaltrialsregister.eu/ctr-search/trial/2017-004886-29/HR">HR</a> (Ongoing)</p>